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ABSTRACT
Embryonic stem cells (ESCs) have attracted intense interest due to their great
potential for regenerative medicine. However, their immune property is an overlooked
but a significant issue that needs to be thoroughly investigated not only to resolve the
concern for therapeutic applications but also for further understanding the early stage of
organismal development. Recent studies demonstrated that ESCs are deficient in innate
immune responses to viral/bacterial infections and inflammatory cytokines. Inflammatory
conditions generally inhibit cell proliferation, which could be detrimental to ESCs, since
cell proliferation is their dedicated task during early embryogenesis. Thus, I hypothesize
that the attenuated innate immunity in ESCs could allow them to evade the cytotoxicity
caused by immune reactions and is, therefore, a self-protective mechanism during early
embryogenesis. We have differentiated mouse ESCs (mESCs) to fibroblast-like cells
(mESC-FBs) which were proved to have partially developed innate immunity. Using
these cells as a model for comparison with mESCs, the insensitivity of mESCs to the
cytotoxic effects from IFN, which is an inflammatory cytokine highly presented during
early embryogenesis, and other inflammatory conditions were demonstrated, including
attenuated expressions of inflammatory and signaling molecules, inactivated transcription
factor and unaffected cell viability. Furthermore, basal expressions of protein
phosphatases that inhibit IFN pathway were higher in mESCs than mESC-FBs. Treating
mESCs with protein phosphatases inhibitor upregulated the expression of IFN induced
signaling molecule. In all, the attenuated inflammatory responses are beneficial for
mESCs, and the inhibition effects from protein phosphatases could, at least, partially
explain their attenuated responses to IFN.
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CHAPTER I - INTRODUCTION
Overview of Innate Immunity
The immune system in vertebrates is composed of two major components, innate
and adaptive immunity. The innate immune system is a primitive defense system found in
all multicellular organisms, and it is known as the first line of defense against the
invasion of different pathogens in an immediate and non-specific manner (Kawai &
Akira, 2011; Medzhitov & Janeway, 2000). In contrast, the adaptive immune system is
pathogen-specific and has only been found in vertebrates that can utilize specialized
immune cells, including T cells and B cells (Hoffmann, Kafatos, Janeway, & Ezekowitz,
1999; Kumar, Kawai, & Akira, 2009a).
The innate immune system is a complex network in which different defending
mechanisms are involved through various signaling pathways. It has been wellestablished that innate immune responses play vital roles in eliminating different
pathogenic invasions. Antibacterial, antiviral, and inflammatory responses are the
primary mechanisms responsible for cellular innate immunity (Medzhitov & Janeway,
2000), which is mainly mediated by large numbers of specific receptors on the surface of
cells or in the cytosol that are known as the pattern recognition receptors (PRRs). In the
meantime, different types of pathogens were suggested to have different conserved motifs
termed pathogen-associated molecular patterns (PAMPs) (Janeway, 1989; Medzhitov,
2009; Mogensen, 2009). When the pathogen invasion occurs, their PAMPs can be
detected by the specific PRRs, and thus initiate the innate immune recognition. These
PRRs then transduce the signals and activate downstream signaling pathway through the
activation of different transcription factors, initiating the activation of a network of innate
1

immune responses that fight off different pathogens and secret different cytokines,
chemokines, and other immunomodulators to alert other tissue cells as well as recruiting
innate immune cells such as dendritic cells, natural killer (NK) cells, and macrophages
(Akira, Uematsu, & Takeuchi, 2006; Hayden, West, & Ghosh, 2006).
PRRs can be divided into different subtypes in terms of their different functions
and recognition of various pathogens. For example, the retinoic acid-inducible gene-1
(RIG-1) receptors (RLRs) and the nucleotide-binding oligomerization domain (NOD)like receptors (NLRs) are both cytosolic and can only respond to intracellular pathogens
(Creagh & O’Neill, 2006). RLRs can be activated by double-stranded RNA (dsRNA)
derived from different viral pathogens (Schlee, 2013) while NLRs respond to bacterial
peptidoglycan (Kanneganti, Lamkanfi, & Núñez, 2007). The toll-like receptors (TLRs)
family are a major group of PRRs, and ten different TLRs have been identified so far
expressing on the cell surface or in the endosomes in humans and mice (designated as
TLR1 through 10) (Beutler, 2009; Kawai & Akira, 2011). For example, TLR3 is
activated by dsRNA generated during viral replication (Alexopoulou, Holt, Medzhitov, &
Flavell, 2001) and a synthetic dsRNA analog, the polyinosinic-polycytidylic acid (poly
I:C), while TLR4 detects lipopolysaccharide (LPS), a major component of gram-negative
bacterial cell membranes (Medzhitov & Janeway, 1997). Another TLR named TLR11
has only been found playing an essential role in mice against parasite and bacterium
(Lauw, Caffrey, & Golenbock, 2005).
Different PRRs bind to their specific ligands and transduce signals into the
cytoplasm, where the downstream transcription factors such as interferon regulatory
factor (IRF) family and nuclear factor-κB (NF-κB) family is activated. Those
2

transcription factors are considered as the master switch of the innate immune responses
and can lead to the production of interferons, inflammatory cytokines, chemokines, cell
cycle regulators and other immunomodulators involved in varieties of immune and
inflammatory responses (Hayden et al., 2006; Kato, Forero, Fenton, & Hidalgo, 2011;
Kawai & Akira, 2011).
Embryonic Stem Cells
The mammal body is composed of trillions of cells, and every cell is descended
from the inner cell mass (ICM) in the early stage embryo, called ESCs. The early stage
embryo, which is developed from a fertilized egg, is named blastocyst. It consists of an
outer layer of trophoblasts, called trophectoderm, which will eventually form the placenta
and the ICM that will develop into the embryo (Irie, Tang, & Azim Surani, 2014).
ESCs have two distinctive characteristics from somatic cells: 1) self-renewal: the
unlimited ability of self-replication in vitro, which means they can proliferate indefinitely
while maintaining stem cell properties under the proper growth condition; 2)
pluripotency: the capability to differentiate into any specialized cell types of the three
primary germ layers (endoderm, mesoderm, and ectoderm) (Brook & Gardner, 1997;
Wobus & Boheler, 2005). These properties make in vitro cultured ESCs a great cell
source for regenerative medicine and tissue transplantation therapy as well as a great
model to study reproductive and stem cell biology (L. Chen & Daley, 2008). The
derivation and differentiation of ESCs are illustrated in Fig. 1.
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Figure 1. Derivation and differentiation of ESCs.
The blastocyst, which is developed from the fertilized egg, is comprised of an outer layer of trophoblasts, called trophectoderm and
ICM. ICM can be isolated and cultured in vitro to yield a population of ESCs, which have the unlimited ability of self-renewal and are
capable of differentiating into all the cell types from each of the three germ layers.

The ability of self-renewal and pluripotency of ESCs are maintained by several
pluripotent markers, which are a group of transcription factors, including Nanog, Oct4,
Sox2, and other signaling modulators. Under the continuous presence and expression of
those molecules, the development and differentiation-promoting genes in ESCs are
negatively regulated (Pinney & Emerson, 1989; Smith, 2001). Recent research indicates
that the characteristics of ESCs are also governed by a group of ESC specific micro
RNAs, such as miR-290 cluster (L. Chen & Daley, 2008; Lüningschrör, Stöcker,
Kaltschmidt, & Kaltschmidt, 2012; Tiscornia & Izpisua Belmonte, 2010). Therefore, the
unique properties of ESCs are maintained by the network of different molecules at both
mRNA and protein level.
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Innate Immunity in Embryonic Stem Cells
ESCs have been considered as the most promising source for the application of
regenerative medicine. For the last two decades, researchers have concentrated on
studying the differentiation from ESCs to desirable cell types as well as optimizing
conditions for specific cell differentiation. However, less attention has been paid to the
immune property of ESCs and their differentiated cells, although this is a critical issue
that will undoubtedly affect the fate and the functionality of the transplanted cells or
tissues when used in regenerative medicine (Guo et al., 2015). Recent studies have
revealed that unlike somatic cells, where innate immunity has been well developed
(Kumar, Kawai, & Akira, 2009b; Sen, 2001), ESCs from both humans (L.-L. Chen,
Yang, & Carmichael, 2010; Földes et al., 2010) and mice (D’Angelo et al., 2017; Wang
et al., 2013; Yu, Rossi, Hale, Goulding, & Dougan, 2009) lack or have attenuated innate
immune responses under the exposure of various infectious agents such as viruses,
bacteria, and inflammatory cytokines. Induced pluripotent stem cells (iPSCs) are also
reported to have the similar underdeveloped innate immune properties (G.-Y. Chen et al.,
2012; Hong & Carmichael, 2013), indicating that the attenuated innate immune system is
intrinsic properties in pluripotent cells. However, the biological implications of the
underdeveloped innate immunity in ESCs are still unclear, and the molecular mechanisms
remain to be further elucidated.
While the modulation of the innate immunity involves complex networks, some
findings from different investigators could partially explain the molecular mechanisms
behind the attenuated innate immunity in ESCs. The studies from our research group
have shown that the expression level of receptors for viral dsRNA, bacterial endotoxin,
5

and several inflammatory cytokines are substantially lower in ESCs (Guo et al., 2015),
and some receptors are not even functional in protein level (D’Angelo et al., 2017;
Zampetaki, Xiao, Zeng, Hu, & Xu, 2006). Furthermore, transcription factor NF-κB (a
family of proteins including p65/RelA, RelB, c-Rel, p50 and p52), which has been known
as a master regulator of innate immune responses as mentioned previously, was not
activated in ESCs under the presence of different infectious agents (D’Angelo et al.,
2016, 2017). One of the key ESC markers Nanog was reported to inhibit the
transcriptional activity of NF-κB by specifically binding to NF-κB protein (Torres &
Watt, 2008). A group of ESC specific micro RNAs was also reported to inhibit the
continuous p65/RelA activation by silencing its mRNA transcription (Lüningschrör et al.,
2012). Taken together, ESCs have intrinsic attenuated innate immune property, which
could be important and necessary for maintaining their self-renewal and pluripotent
capability. This study is intended to provide experimental evidence to support this
hypothesis.
Inflammatory Responses
Inflammatory responses usually occur during the infections caused by the
invasion of different pathogens or around the wounded areas in the body. Some noninfectious diseases such as cancer, diabetes, and arthritis could also induce inflammation.
Thus, the inflammatory responses are considered a series of self-healing reactions to
restore the tissue inner environment to homeostasis (Medzhitov, 2010). The inflammatory
responses are mainly regulated by a group of innate immune cells, which are also called
tissue-resident sentinel cells, such as macrophages, mast cells, NK cells, and dendritic
cells. The acute inflammation is initiated by those cells either through the direct sensation
6

of different PAMPs or by the chemical factors that secreted from other infected cells
through a paracrine manner. Then, those innate immune cells can further produce
different types of inflammatory cytokines, chemokines, and free radicals that limit the
spread of infections and activate adaptive immune system (Conner & Grisham, 1996). It
should be noted that while the inflammatory responses can defend the organism against
the invading pathogens, they can also have detrimental effects on tissue cells such as cell
proliferating inhibition, cell damage, and apoptosis (Hertzog, Hwang, & Kola, 1994;
Kotredes & Gamero, 2013; Sedger & McDermott, 2014). Thus, the inflammation
response is considered to be a double-edged sword.
TNF and IFN Signaling and Their Roles in Inflammatory Responses
Among the various inflammatory cytokines, TNF and IFN are particularly
known for causing cytotoxicity and inflammation. TNF is one of the most potent proinflammatory cytokines produced by activated innate immune cells such as macrophages
and NK cells during the acute inflammatory reaction as well as non-immune cells such as
fibroblasts and endothelial cells (Falvo, Tsytsykova, & Goldfeld, 2010). As initially
characterized, TNF can signal apoptosis but mainly in tumor cells, virus-infected cells
or cells under cell cycle arrest. In those scenarios, the extracellular TNF binds to TNFR
and induce the release of silencer of death domain (SODD) protein, resulting the
recruitment of death-inducing signaling complex (DISC) proteins, which include TNFRassociated death domain (TRADD), TNFR-associated factor (TRAF), Fas-associated
death domain (FADD) and receptor interacting protein (RIP). Upon the recruitment of
DISC proteins, they can further recruit procaspase-8 and procaspase-3 that will
subsequently release the activated caspase-8 and caspase-3, inducing the caspase7

activated DNase (CAD), which can degrade genomic DNA, cause DNA fragmentation
and induce caspase-dependent cell death. While in normal tissue cells, TNF does not
usually cause apoptosis. Instead, it can activate the global trans-activator NF-κB and
other non-apoptotic signaling pathways such as mitogen-activated protein kinase
(MAPK) and cJun N-terminal kinase (JNK) and induce a panel of chemokines and
inflammatory mediators, which will further monitor the immune microenvironment
(Horssen, Hagen, & Eggermont, 2006; Sedger & McDermott, 2014). NF-κB signaling
activation, in particular, is the major event of TNF induction and plays significant roles
in regulating cell survival and inflammatory responses. Upon binding of TNF ligand
with its receptor TNFR, a complex of inhibitor of NF-κB (IκB) kinase (IKK), which
comprises IKK, IKK and Nemo/IKK, is activated and can subsequently
phosphorylate and degrade IκB. IκB binds to NF-κB and inhibits its translocation to the
nucleus in inactivated cells. With the release from IκB, NF-κB p50 and p65/Rel can
translocate to the nucleus and bind to their binding sites on the target gene promoters,
inducing the transcription of various genes involved in immune and inflammatory
responses such as interferons, different chemokines, and cell adhesion molecules. (Mak
& Yeh, 2002). TNF signaling regulation is schematically illustrated in Fig. 2. It is noted
that TNF can induce and has synergistic effects with interferons, and interferons can, in
turn, upregulate the expression levels of TNFR, which could partially explain their
synergy (Sedger & McDermott, 2014).
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Figure 2. Schematic illustration of TNF signaling pathway.
TNF regulates both apoptosis and survival pathways. The apoptosis signaling induced by TNF is caspase-dependent and only occur
when there is an aberration within the cells. In normal tissue cells, TNF can induce non-death signaling pathway via the activation of
transcription factors NF-B and cFos/cJun. NF-B is an important global trans-activator. During its activation, the IKK complex is
initially activated through binding of TNF with their receptors. Activated IKK complex then induces subsequent ubiquitination and
degradation of IκB, which enable NF-B proteins to translocate to the nucleus and induce transcription of various inflammatory
mediators such as inflammatory cytokines, chemokines, and genes that regulate cell proliferation.

IFN is the only member of the type II class interferon and is one of the most
commonly found inflammatory cytokines at the site of pathogen infections (Boehm,
Klamp, Groot, & Howard, 1997; Stark, Kerr, Williams, Silverman, & Schreiber, 1998)
and in the placenta during the early stage of fetal development in mammals (Ashkar, Di
Santo, & Croy, 2000; Platt & Hunt, 1998). It is mainly produced by T lymphocytes and
NK cells, and involves in multiple processes of innate and adaptive immune responses
via autocrine and paracrine manner, including antigen presentation, inhibition of cell
9

proliferation, and cell apoptosis (Schroder, Hertzog, Ravasi, & Hume, 2004). The signal
transduction of IFN is regulated by the JAK-STAT pathway (Fig. 3). Binding of IFN to
its receptors on the cell surface, which are composed of IFNR1 and IFNR2, leads to the
activation of the receptor-associated tyrosine kinase JAK1 and JAK2. The activated JAKs
induce the phosphorylation of the tyrosine residue at the IFNR1 intracellular domain.
STAT1 are then subsequently recruited to the intracellular portion of the IFNR complex
and get phosphorylated on the tyrosine residue (Tyr) 701 by the JAKs. Tyrosine
phosphorylation of STAT1 leads to their homodimerization and translocation to the
nucleus. By binding at the IFN-activating sequence (GAS) in the nucleus,
phosphorylated STAT1 can activate the transcription of different primary response genes
that contain the GAS within their promoters, one of which is the gene encoding IRF1
(Boehm et al., 1997; Darnell, 1997; Platanias, 2005). The elevated amount of IRF1 can
bind to interferon-stimulated response element (ISRE), which is another specific
nucleotide sequence, inducing the transcription of secondary response genes (Kröger,
Köster, Schroeder, Hauser, & Mueller, 2002). Excessive and uncontrolled IFN
responses could cause deleterious effects on tissue cells, but this can be limited by
negative regulators including suppressor of cytokine signaling 1 (SOCS1), protein
tyrosine phosphatase (PTP), dual specificity phosphatase (DSP), and protein inhibitor of
activated STAT (PIAS) (Greenhalgh & Hilton, 2001; Shuai & Liu, 2003; T. R. Wu et al.,
2002).
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Figure 3. Schematic illustration of IFN signaling pathway.
Binding of IFN to the extracellular domain of the IFNR complex leads to the phosphorylation of JAKs and the intracellular domain
of the receptors. STAT1 are then subsequently recruited to the receptors and are phosphorylated, which leads the homodimerization
and nucleus translocation of p-STAT1. Inside the nucleus, p-STAT1 homodimers bind to GAS and induce the primary transcription of
different genes, including IRF1. By binding to ISRE, IRF1 can further activate the transcription of secondary response genes.

Transcription factors act like “switches” to different inflammation signaling
pathways (Oeckinghaus & Ghosh, 2009). Our previous studies have demonstrated that
NF-B, a transcription factor responsible for TNF responses, could not be activated in
mESCs (D’Angelo et al., 2017). It was reported by other researchers that Nanog, a
critical pluripotent marker of ESCs (Torres & Watt, 2008), and a group of ESC-specific
miRNA (Lüningschrör et al., 2012) are inhibiting the transcriptional activity of NF-B in
mESCs. These results provide possible explanations for the lack of TNF responses in
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mESCs. However, the reason behind the lack of responses to IFN in mESCs is still not
clear.
Innate Immune Responses During Early Embryogenesis
As an evolutionarily conservative defense system in vertebrates, the innate
immune responses have been known to be the prominent events through the fetal
development in the uterus (Warning, McCracken, & Morris, 2011; Wira, Fahey,
Sentman, Pioli, & Shen, 2005). There are elevated amounts of uterine immune cells (e.g.,
NK cells) and inflammatory molecules especially before and during the process of
implantation (Cram, Zapata, Toy, & Baker, 2002; Lamont, 2003; PrabhuDas et al., 2015).
The abnormal change of the levels of different cytokines and chemokines, which play
pivotal roles in balancing the microenvironment in the uterus, is one of the main factors
that cause failed pregnancy and recurrent miscarriages (Mor, Cardenas, Abrahams, &
Guller, 2011; Murphy, Thompson, & Belov, 2009; Sykes et al., 2012). Therefore, the
precise regulation of the innate immune responses in the cells during the early embryonic
stages is crucial for successful embryo and fetus development. Recent studies have
revealed that ESCs, as the progenitors of all the tissue cells, have attenuated innate
immune responses to a wide range of inflammatory cytokines (Burke, Graham, &
Lehman, 1978; D’Angelo et al., 2017; Hong & Carmichael, 2013; Wang et al., 2014).
IFNs and other inflammatory cytokines are well-known to have anti-proliferation effects
and can induce cell apoptosis as mentioned previously. While ESCs are only transiently
existed in limited numbers in the blastocyst, the damage or loss of ESCs could cause
severe developmental deficiencies (Naeye & Blanc, 1965). For this reason, the attenuated
responses to inflammatory cytokines could be beneficial for ESCs and the early embryo
12

to evade the detrimental effects caused by inflammatory responses, which is the major
hypothesis of this study.
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CHAPTER II - HYPOTHESIS AND SIGNIFICANCE
Based on the unlimited ability of self-replication and the potential to be
differentiated into any specialized cell type in the body, ESCs and their derived cells have
been considered as one of the most promising sources for applications in tissue
transplantation and regenerative medicine (Keller, 2005; Soria et al., 2000; Wobus &
Boheler, 2005). While researchers have been concentrating on optimizing in vitro
differentiation conditions from ESCs to various desirable cell types for therapeutic
application, innate immune response, which is the first line of defense against the
invasion of different pathogens and have been widely studied in somatic cells, are often
overlooked on ESCs. Recent studies from our group and other investigators demonstrated
that ESCs from both mouse and human intrinsically lack or have underdeveloped innate
immune responses. They exhibit little or no responses to varieties of infections, including
viruses (Wang et al., 2013), bacteria (Földes et al., 2010), and various inflammatory
cytokines (D’Angelo et al., 2017; Kim et al., 2008). Although it has been proven that the
innate immunity is being developed during ESC differentiation process, it is still
substantially underdeveloped in in vitro differentiated ESCs compared with their
naturally differentiated counterparts (Guo et al., 2015). Understanding the innate immune
system in ESCs becomes much more important especially for this special group of cells
to be used for clinical treatment. While these properties of ESCs not only raise concerns
for their therapeutic use, they also represent fundamental questions in stem cell and
developmental biology that need to be reevaluated.
In this study, I further demonstrated the effects of various inflammatory
conditions on mouse ESCs, including the cytotoxicity, induction of the inflammatory
14

genes, and the activation of transcription factors. The potential molecular mechanisms
that account, at least in part, for the attenuated innate immune responses in ESCs were
also demonstrated. The immunological properties of ESCs described in this study will
help us assess their clinical application as well as understand the fundamental biological
questions at the early stage of the development.
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CHAPTER III - MATERIALS AND METHODS
Cell Culture and mESC Differentiation
Two commonly used mESCs cell lines: D3 and DBA252 mESCs were cultured in
the standard mESC medium as described before (Wang et al., 2013). mESC-FBs were
differentiated from D3 and DBA252 mESCs through a retinoic acid (RA) induced
differentiation protocol and purified by reseeding them to an uncoated dish, to which they
will quickly adhere (Wang et al., 2014). The medium was changed to remove the
unattached cells after 10 min of seeding. Since both D3 and DBA252 cells and their
differentiated cells (D3 or DBA252 mESC-FBs) share similar properties as characterized
from previous studies (Wang et al., 2013), the experiments in this study were mainly
performed with D3 mESCs and their differentiated mESC-FBs. mESC-FBs between
passage 10-35 were used for this study. Some key experiments were confirmed with
DBA252 mESCs. RAW264.7 cells (a murine macrophage cell line) were obtained from
ATCC. mESC-FBs and RAW264.7 were cultured in 10% fetal bovine serum (FBS)
DMEM with 100 units/ml penicillin and 100g/ml streptomycin. In some specific
experiments, medium was changed to 2% FBS DMEM before the treatments were added
to maximize the responses of cells. Different conditions will be described for individual
experiments. All cells were maintained at 37°C in a humidified incubator with 5% CO2.
Preparation of Conditioned Medium, Heat Killed Bacteria, and Cell Treatment
RAW264.7 cells (50-70% confluence) were treated with LPS (1g/ml, isolated
from E. coli O111: B4, Sigma) for 4 h. Then the medium was removed, and cells were
thoroughly washed twice with PBS. Fresh medium was added to culture cells for an
additional 24 h. The CM was collected and designated as LPS CM. CM prepared from
16

RAW264.7 cells that without any treatment was used as control (Con CM). Heat killed E.
coli (O157: H7, ATCC) (HKE) were prepared by heating bacteria at 80 oC for one hour
(Koziel et al., 2009). mESCs and mESC-FBs were treated with CM (1:1 diluted with
10%FBS DMEM), HKE (bacterial:mESCs or mESC-FBs at a ratio of 200:1), TNFα, or
INFγ (20ng/ml, Peprotech. Supplement of IFNγ were added at 5ng/ml) under the
condition as described in each individual experiment.
Quantitative Analysis of Cell Viability
Cells were fixed with cold methanol for 10 min at room temperature, followed by
staining with 1% toluidine blue (TB, Sigma) in dH2O for 30 min. Cells were then rinsed
with tap water to remove excess TB, and 2% SDS (Sigma) was added to extract the
staining. Optical density at 630 nm, which correlates with the number of cells, was
measured with a BioTek ELx800 microplate reader.
RT-qPCR
Cells were collected using TRI-reagent (Sigma), followed by phenol-chloroform
extraction of the whole RNA. Total RNA concentration in each sample was determined
by a Thermo Genesys 10 Bio UV-Vis spectrophotometer. 1g RNA from each sample
was used for reverse transcription to generate cDNA with Moloney murine leukemia
virus (MML-V) reverse transcriptase (Promega). RT-qPCR was performed using SYBR
green supermix (Bio-Rad) on a Stratagene Mx3000P real-time PCR system with genespecific primers. β-actin was used as a calibrator to normalize different genes for
comparison. The expression levels of mRNA were either normalized with controls
(designated as 1) and expressed as fold change activation, or normalized with β-actin
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(designated as 1) and expressed as relative levels. The sequences of the primer sets
utilized for RT-qPCR are listed in Table 1.
Table 1
Primer sequences of mouse genes for RT-qPCR analysis
Gene
β-actin
iNOS
Cox2
STAT1
IRF-1
SOCS1
IFNR1
IFNR2
JAK1
JAK2
MKP1
PTPN2
SHP-1
SHP-2

Sequence (forward)

Sequence (reverse)

CATGTACGTAGCCATCCAGGC
CAGCACAGGAAATGTTTCAGC
TGAGCAACTATTCCAAACCAGC
GCTGCCTATGATGTCTCGTTT
ATGCCAATCACTCGAATGCG
CTGCGGCTTCTATTGGGGAC
CTGGCAGGATGATTCTGCTGG
TCCTCGCCAGACTCGTTTTC
ACGCTCCGAACCGAATCATC
TTGTGGTATTACGCCTGTGTATC
ATGCAGCTCCTGTAGTACCC
GCAGTGAGAGCATTCTACGGA
GGACTTCTATGACCTGTACGGA
AGAGGGAAGAGCAAATGTGTCA

CTCTTTGATGTCACGCACGAT
TAGCCAGCGTACCGGATGA
GCACGTAGTCTTCGATCACTATC
TGCTTTTCCGTATGTTGTGCT
TTGTATCGGCCTGTGTGAATG
AAAAGGCAGTCGAAGGTCTCG
GCATACGACAGGGTTCAAGTTAT
GTCTTGGGTCATTGCTGGAAG
GTGCCAGTTGGTAAAGTAGAACC
ATGCCTGGTTGACTCGTCTAT
ATATCCTTCCGAGAAGCGTGA
TGACACAAACCCCATCTTAGTGA
CGAGCAGTTCAGTGGGTACTT
CTGTGTTTCCTTGTCCGACCT

Flow Cytometry
For cell cycle analysis, cells were collected and fixed with 80% ethanol for 1 h,
then stained with 50 g/ml propidium iodide (PI). For cellular protein analysis, either
control cells or treated cells were collected and fixed with 3% paraformaldehyde. The
cells were incubated with antibodies against specific proteins, including antibodies for
iNOS (sc-7271), IFNR1 (sc-12755), JAK1 (sc-1677), JAK2 (sc-390539), p16 (sc-1661),
p21 (sc-6246), MKP1 (sc-370), MKP2 (sc-1200), SHP-1 (sc-7289), SHP-2 (sc-7384),
SOCS1 (sc-9021)(Santa Cruz Biotechnology), and IFNR2 (#559917, BD Biosciences).
Then the cells were incubated with secondary antibodies conjugated with fluorescence
dye and examined with an Accuri C6 flow cytometer (BD Biosciences). The results were
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generated by a CFlow software where protein expression was determined by their
different fluorescence intensity.
Immunocytochemistry
Immunostaining was performed in a mESCs and mESC-FBs co-culture model
(D’Angelo et al., 2016) where both cells can be easily distinguished by their different cell
morphology. Both cells will be seeded on the top of cover glasses in a cell culture plate
followed by designated treatments. Cells will then be fixed with 3% paraformaldehyde
and permeabilized with 0.1% Triton-X100. The cellular location of STAT1 was
determined by P-STAT1 antibody specific to Tyr 701 phosphorylated site (#7649, Cell
Signaling Technology) and a secondary antibody conjugated with fluorescein
isothiocyanate (FITC). The cells were visualized under a Zeiss LSM510 laser-scanning
confocal microscope.
Statistical Analysis
Statistical analysis was performed using a 2-tailed and paired student t-test.
Differences are considered statistically significant when *p < 0.05 and statistically highly
significant when ** p < 0.01.
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CHAPTER IV – RESULTS
The research in our lab has been concentrated on studying the innate immunity of
mouse ESCs (mESCs), and we found that mESCs lack or have the attenuated ability to
mount the innate immune responses in the presence of bacterial/virus infections and
inflammatory cytokines (D’Angelo et al., 2017; Wang et al., 2014, 2013). Along with
studies from other researchers on both human ESCs (hESCs) and mESCs (L.-L. Chen et
al., 2010; Földes et al., 2010; Yu et al., 2009), we have concluded that the lack of innate
immune responses is an intrinsic property of ESCs. However, the rationales of lacking
such fundamental abilities in ESCs and the implications of their underdeveloped innate
immunity are still not clear. To understand the molecular mechanisms underlying these
findings, I used a differentiated model of mESCs called mESC-FBs, which were proved
to have partially developed innate immune responses in comparison with mESCs.
Briefly, I removed LIF (a cytokine that inhibits differentiation of mESCs) from the
mESCs culture medium and treated mESCs with 1 µM retinoic acid (a vitamin A
metabolite that can induce differentiation). After 10 days of’ spontaneous culture, the
morphology of a large portion of the cells turned into a spindle shape and became flatter
than the original mESCs colonies. Those cells were then purified by reseeding to a new
dish and changing the medium within 10-15 min to remove unattached cells. The pure
fibroblast morphology was shown on the remaining cells, which are designated as mESCFBs (Wang et al., 2013). The subject of this research project is to demonstrate the
implications of the attenuated responses to various inflammatory conditions in mESCs
and the possible molecular regulating mechanisms. The results are summarized below.
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mESCs Are Insensitive to the Cytotoxicity of IFNγ and TNFα
Somatic cells and immune cells can secrete large numbers of IFNs and
inflammatory cytokines when they have encountered viral, bacterial, or other types of
infections to defend themselves and nearby infected cells (Mogensen, 2009; O’Shea &
Murray, 2008). TNF and IFN are the two most common inflammatory cytokines found
in inflammation conditions. Large amounts of TNF or IFN production caused by
infections could negatively affect the functionality and propagation of cells (Buntinx et
al., 2004; Ohmori, Schreiber, & Hamilton, 1997). Inflammatory cytokines like TNF or
IFN alone usually does not cause apparent effects on cell viability within a short time
frame, but when they are presented together, they can synergistically potentiate their
cytotoxicity and cause cell death. By treating mESCs and mESC-FBs with either TNF
and IFN by themselves or in combination, I first aimed to test the effects of this
artificially created inflammatory condition on cells viability. After incubating for 48 h in
2% FBS DMEM, TNF or IFN alone did not have significant effects on cell viability in
both mESCs and mESC-FBs, but the combination of these two cytokines caused
significant cell proliferation inhibition in mESC-FBs (~70% of cells lost viability by 48
h; toxicity was apparent as early as 24 h), while no effects occurred in mESCs (Fig. 4A).
To determine the impacts from IFN alone on both cell types for a longer time, cells were
then treated for 4 days under the same culture condition as in Fig. 4A, and once again,
~50% loss of viability in mESC-FBs was observed, but there were no effects in mESCs
(Fig. 4B). To further confirm the effects of TNF and IFN, both mESCs and mESC-FBs
were treated with either of the two cytokines alone or their combination for 24 h and
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analyzed their cell cycle by propidium iodide (PI) using a flow cytometer. As shown in
Fig. 4C, decreased cell numbers in the S and G2 phase were only found in TNF and
IFN treated mESC-FBs, which confirmed the cytotoxicity from TNF and IFN only
occurred in mESC-FBs.
p16 and p21 are two primary cell proliferation regulators and are widely used as
senescent markers (Harada, Taniguchi, & Tanaka, 1998; Stark et al., 1998). To further
demonstrate the effects of TNF and IFN on the cellular level, protein expressions of
p16 and p21 in mESCs and mESC-FBs were examined by flow cytometry after 24 h
treatment of both cytokines. As shown in Fig. 4D, both p16 and p21 expressions clearly
increased in mESC-FBs after treatment of cytokines, but again, no effects were detected
in mESCs. All the results above indicate that by lacking responses to those inflammatory
cytokines, mESCs could potentially evade from the harmful effects caused by
inflammation and protect their pluripotent identity.
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Figure 4. Effects of IFNγ and TNFα on the viability of mESCs and mESC-FBs.
(A) ESCs and ESC-FBs were treated with either TNFα (20ng/ml), IFNγ (20ng/ml) alone or TNFα plus IFNγ. After 48h treatments,
both cells were fixed and stained with toluidine blue as an indicator of cell viability analysis. The cell number in control (Con) was
defined as 100%. (B) ESCs and ESC-FBs were treated with IFNγ (20ng/ml) for 4 days. Quantitative analysis of the cell viability was
performed as discussed above. Data are mean ± SD of a representative experiment that was performed in triplicate. *P < 0.05, **P <
0.01. (C) ESCs and ESC-FBs were treated with TNFα, IFNγ or their combination for 24 h, then collected and stained with 50µg/ml
propidium iodide for cell cycle analysis by flow cytometry. Reduction of the S and G2/M phase cells were indicated by arrow and
arrowhead. (D) Both cells were treated with TNFα plus IFNγ for 24 h, then the expression of p16 and p21 were analyzed by flow
cytometry. The lines denoted by arrows are negative controls that were only stained with secondary antibody. Flow cytometry data
was derived from a representative experiment that was performed twice yielding similar results.
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mESCs Have Attenuated Responses to IFNγ and TNFα
From our previous studies, we have already demonstrated that mESCs lack
responses to TNF and the responses could be gradually developed during differentiation
of mESCs to mESC-FBs (D’Angelo et al., 2016). In Fig. 4, IFN alone or with the
combination of TNF did not have any significant effect on the cell viability of mESCs.
However, whether IFN itself or the combination with TNF can alter the expression of
signaling or inflammatory genes of mESCs is still not clear. Thus, the effects of TNF
and IFN alone or their combination on the mRNA expression of signaling molecules in
mESCs and mESC-FBs were first determined. iNOS is an important cytokine-inducible
factor synthesized by cells in response to different infections (Zamora, Vodovotz, &
Billiar, 2000). ISG15 can also be induced by IFN during immune responses (Cunha,
Knight, Haast, Truitt, & Borden, 1996). Both iNOS and ISG15 play essential roles in
regulating cell proliferation and responses to the infections. The expression levels of
these two inflammatory molecules after the treatment with TNF and IFN were tested
first. As shown in Fig. 5A(a), significant effects of IFN or its synergistic combination
with TNF were only seen in mESC-FBs, but they were barely changed in mESCs. The
dose-dependent treatment of IFN further demonstrated the attenuated responses in
mESCs (Fig. 5A(b)). The expression of iNOS protein induced by TNF and IFN in
mESC-FBs were then confirmed by flow cytometry, where no detectable protein changes
were found in mESCs (Fig. 5B). Based on these results, it was further confirmed that
mESCs have attenuated responses to IFN and did not have significant responses to the
synergistic effects from its combination with TNF.
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Figure 5. Attenuated responses of mESCs to IFNγ and TNFα.
ESCs and ESC-FBs were treated with TNFα (20ng/ml), IFNγ (20ng/ml) and their combination for 24 h (A(a)) or treated with different
concentration of IFNγ for 12 h (A(b)). The control cells were left untreated. The mRNA level of iNOS and ISG15 was determined by
RT-qPCR. The results are presented as fold-activation; the mRNA level in untreated control cells is designated as 1. (B) The effect of
IFNγ or TNFα plus IFNγ on the protein expression of iNOS in ESCs and ESC-FBs were determined by flow cytometry (denoted by
arrowheads). The lines denoted by arrows represent controls. RT-qPCR data are mean ± SD of representative experiments from three
independent experiments. Flow cytometry data are derived from a representative experiment that was performed three times yielding
similar results.

mESCs Are Insensitive to the Cytotoxicity Associated with Macrophage Activation
It can be concluded from the results above that TNF and IFN did not affect the
overall viability of mESCs and barely induced the expression of inflammatory genes.
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However, the immune system and signaling pathways in vivo are complicated and are
involved in numerous other inflammation molecules. Thus, we created an in vitro
inflammation model by making the conditioned medium from macrophages
(RAW264.7), which are known to have robust immune responses when activated by
infectious agents and secret a large amount of various inflammatory molecules (Funk,
Feingold, Moser, & Grunfeld, 1993; Lyu & Park, 2005). Briefly, RAW cells were either
left untreated or treated with lipopolysaccharide (LPS; a bacterial endotoxin that strongly
induces inflammatory responses) (Hambleton, Weinsteint, Lemt, Defrancots, & Bishop,
1996). Then, those media were collected and named as Con-CM and LPS-CM,
respectively. The Con or LPS-CM were mixed with cell culture medium at a 1:1 ratio and
were used to culture both cell types for 48 h, followed by the cell viability analysis. As
shown in Fig. 6A, similar patterns from LPS-CM were observed compared with the
effects from TNF and IFN as indicated by the first two bars in the bar graph of each
cell type: LPS-CM caused more than 40% inhibition of cells proliferation in mESC-FBs
but had no effects on mESCs. Although it is not clear what the major molecules are in the
CMs, there could be synergistic effects under the presence of additional cytokines (Bartee
& McFadden, 2013; Cassese et al., 2003). Thus, supplement of IFN was added to
another group of Con and LPS CM cultured mESCs and mESC-FBs to see if there were
synergistic effects. As shown in Fig. 6A, the supplement of IFN caused additional
toxicity, once again, only in mESC-FBs, under both Con and LPS CM cultured
conditions. No significant effects were detected in mESCs. The effects from CM and
supplement of IFN were further confirmed from the mRNA level by determining the
expression of iNOS and COX2, two major inflammatory molecules induced during
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inflammation under the same condition as the cell viability experiments. These genes
were barely induced in mESCs under all conditions tested (Fig. 6B).

Figure 6. Effects of CM in the presence or absence of IFNγ on the viability and
inflammatory gene expression in mESCs and mESC-FBs.
(A) ESCs and ESC-FBs were treated either with conditioned medium from untreated (Con CM) or LPS treated RAW cells (LPS CM)
1:1 mixed with cell culture medium (first two bars in each cell type) or with additional IFNγ (5ng/ml) for 48 h. Cells were stained with
toluidine blue as an indicator of cell viability analysis. The cell number in controls (Con) were defined as 100%. (B) mRNA
expression of iNOS and Cox-2 were determined after the same treatment for 24 h as described in (A) by RT-qPCR. Data are mean ±
SD of a representative experiment that was performed in triplicate or from three independent experiments. *P < 0.05.

IFNγ Potentiates the Cytotoxic Effects of Heat Killed E. coli in mESC-FBs but Not in
mESCs
To further demonstrate the insensitivity to the cytotoxic effects from various
inflammatory conditions in mESCs, HKE was used to illustrate the effects of bacterial
infection agents. mESCs and mESC-FBs were incubated with HKE, alone or in
combination with IFNγ. As shown in Fig. 7, over a 4-day treatment period, HKE alone
had no significant effects on the viability of either cell type, but supplementation of IFNγ
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with HKE induced synergistic cytotoxicity in mESC-FBs, though this combination still
had no effects on the viability of mESCs.

Figure 7. IFNγ potentiates the toxicity of HKE in mESC-FBs but not in mESCs.
ESCs and ESC-FBs were treated either with HKE (200:1 with cells), IFNγ (20ng/ml) alone or their combination for 4 days in 10%
FBS DMEM. Cells were stained with toluidine blue as an indicator of cell viability. The cell number in controls (Con) was defined as
100%. Data are mean ± SD of a representative experiment that was performed in triplicate. *P < 0.05, **P < 0.01.

STAT1 Is Not Activated by IFNγ in mESCs
STAT1 is the initial and major transcription factor that controls interferons
responses (Lehtonen, Matikainen, & Julkunen, 1997). The activation of STAT1 can
induce the downstream transcription factor IRF-1, which will further regulate the
downstream IFN pathway (Platanias, 2005). To further determine the molecular basis
for the attenuated IFN response in mESCs, I first tested IRF-1 and STAT1 mRNA basal
level and IFN induction level in both mESCs and mESC-FBs. Interestingly, as shown in
Fig. 8A(a), mRNA basal levels of both IRF-1 and STAT1 are significantly higher in
mESCs than mESC-FBs. However, IFN treatment results in a 5-fold increase in mRNA
expression of each gene in mESCs, compared with a 25-30 fold increase in mESC-FBs
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(Fig. 8A(b)). When STAT1 is activated, it will be phosphorylated (P-STAT1) on both
tyrosine and serine sites. P-STAT1 can then be translocated from cytoplasm to the
nucleus and bind to their promoter regions of target genes to initiate transcription. To
monitor the nuclear translocation of P-STAT1, an antibody-based immunocytochemistry
assay and a co-culture model were used, where mESCs can be easily distinguished by
their characteristic cell morphology and colonial growth (as indicated within the circled
areas) compared with mESC-FBs. As shown in Fig. 8B, P-STAT1 can be detected in the
cytoplasm of both cell types in CON. However, nuclear translocation was only detected
in mESC-FBs after the treatment of IFN, while no detectable changes occurred in
mESCs. We previously demonstrated that mESCs could respond to type I IFN, and
STAT1 was able to be translocated into the nucleus after IFN induction, indicating that
STAT1 nuclear translocation is functional in mESCs (Wang et al., 2014). Therefore,
there must be other mechanisms responsible for the attenuated response to IFN in
mESCs.
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Figure 8. Expression of IRF-1 and STAT1 and the effects of IFNγ on STAT1 activation
in mESCs and mESC-FBs.
(A) IRF-1 and STAT1 mRNA expression in both ESCs and ESC-FBs. The basal mRNA expression levels of IRF-1 and STAT1 in
mESCs and mESC-FBs were determined by RT-qPCR (a). The mRNA induction of IRF-1 and STAT1 by IFNγ was attenuated in
mESCs in comparison with mESC-FBs. Both cell types were treated with IFNγ (20ng/ml) for 24 h and then collected for RT-qPCR
(b). Data are mean ± SD of representative experiments from three independent experiments. *P < 0.05. (B) IFNγ induced nuclear
translocation of STAT1 in ESC-FBs but not in ESCs. ESCs and ESC-FBs were grown in a co-culture model in which ESCs were
identified by their colonial growth (dotted circle area), and ESC-FBs were identified by their flattened large cell morphology. The
cells in the co-culture were treated with IFNγ (20ng/ml) for 15 min, and the cellular location of STAT1 was analyzed with Abs against
Tyr701 P-STAT1. Arrows indicate the representative nuclei. The images were from representative experiments performed in
duplicate. CON represents cells that were not treated.

Relative Expression Levels of IFNγ Signaling Molecules in mESCs and mESC-FBs
We have demonstrated that transcription factor STAT1 was activated by type I
IFN (IFN and ) (Wang et al., 2014), but not by IFN in mESCs (Fig. 8). It is uncertain
if the signaling receptors responsible for IFN are functional. IFNR1 and IFNR2 are
located at the cell membrane and contain intracellular and extracellular domains. Their
extracellular domains are mainly responsible for IFN binding, while the intracellular
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domains bind with their receptor-associated factors JAK1 and JAK2 to further transduce
the signals (Darnell, 1997). Relative mRNA expression of signaling molecules mentioned
above in both mESCs and mESC-FBs were analyzed by RT-qPCR. As shown in Fig. 9A,
mRNA of these major signaling molecules were expressed in both cell types, although
some of them were expressed relatively lower in mESCs compared with mESC-FBs. At
the protein level, these signaling molecules were also detectable in both cell types (Fig.
9B), indicating that the major signaling molecules of IFN pathway are present in
mESCs, and other regulating mechanisms might be responsible for the attenuated IFN
responses in mESCs.

Figure 9. Expression of signaling molecules that regulate IFNγ responses in mESCs and
mESC-FBs.
(A) Relative basal mRNA level of each gene in ESCs and ESC-FBs was compared after normalization to 𝛽-actin mRNA in each cell
type. (B) Expression of signaling molecules in ESC and ESC-FB was determined by flow cytometry (the lines denoted by
arrowheads). The lines denoted by arrows represent negative controls. RT-qPCR data are mean ± SD of representative experiments
from three independent experiments. *p < 0.05. Flow cytometry data are derived from a representative experiment that was performed
three times yielding similar results.
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SOCS1 Is Not a Critical Suppressor Responsible for the Attenuated IFNγ Responses in
mESCs
SOCS1 plays critical roles in regulating the IFN signaling pathway. By
interacting with the IFN receptor-associated factor JAK2, SOCS1 can inhibit STAT1
phosphorylation by JAK2 and thus inhibit the signal transduction activity (Fig. 3)
(Alexander et al., 1999; Davey, Heath, & Starr, 2006; Naka & Fujimoto, 2010). Unlike
type I IFN activation, where STAT1 forms a heterodimer with STAT2 before
translocation into the nucleus, P-STAT1 will form a homodimer after cell activation by
IFN. Homodimerization of P-STAT1 is a prerequisite for them to be translocated into
the nucleus in response to IFN (Platanias, 2005). To determine whether SOCS1medicated inhibition could be one of the reason that accounts for the attenuated IFN
responses in mESCs, I first tested the basal mRNA and protein expression level of
SOCS1 in mESCs and mESC-FBs. Both mRNA and protein basal expression of SOCS1
in mESCs were found to be lower than mESC-FBs. (Fig. 10A (a and b)). Next, both cells
were treated with IFN for 15 h or 24 h and then SOCS1 induction was analyzed at the
mRNA and protein levels. As shown in Fig. 10B (a), SOCS1 mRNA was significantly
upregulated by IFN in mESC-FBs, and the induction level was around 4 times more than
in mESCs. Consistent with SOCS1 mRNA induction, SOCS1 protein expression was also
increased in IFN treated mESC-FBs but not in mESCs (Fig. 10B(b)). To further
demonstrate the role of SOCS1 in the regulation of responses to IFN, mESCs were
either transfected with Con siRNA or siSOCS1 (30nM). Optimal transfection conditions
were determined first (data not shown). Transfection of siSOCS1 resulted in knockdown
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SOCS1 mRNA expression by more than 40% in mESCs at 19 h after transfection. After
19 h transfection, mESCs were treated with IFN for another 12 h. The mRNA induction
levels of iNOS in Con siRNA- and siSOCS1-transfected mESCs were determined by RTqPCR. The results indicated that knocking down of SOCS1 had no effect on the induction
level of iNOS by IFN in mESCs (Fig. 10C). In conclusion, SOCS1 may not be a critical
suppressor of mESCs’ responses to IFN.

Figure 10. SOCS1 is not a critical suppressor responsible for the attenuated IFNγ
responses in mESCs.
(A) Relative basal mRNA level of SOCS1 in ESCs and ESC-FBs was compared after normalization to 𝛽-actin mRNA in each cell
type (a). The basal protein level of SOCS1 was determined by flow cytometry (As indicated by the arrowhead) (b). (B) Effects of
IFNγ (20ng/ml) on the mRNA and protein expression of SOCS1 in ESCs and ESC-FBs were determined by RT-qPCR and flow
cytometry. (C) ESCs were transfected either with Con siRNA or siSOCS1 for 19 h. Transfection efficiency was determined by mRNA
levels of SOCS1. Cells were then treated with IFNγ for another 12 h. iNOS mRNA expression (%) was determined as normalized with
Con. RT-qPCR data are mean ± SD of representative experiments from three independent experiments. *p < 0.05. Flow cytometry
data are derived from a representative experiment that was performed twice yielding similar results.
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Relative Expression Levels of PTPs That Regulate IFNγ Signaling and the Effects of
IFNγ on Their Expressions
Protein phosphorylation is essential for many types of signal transduction,
including the responses to cytokines, and growth factors. Tyrosine and serine
phosphorylation are central regulators of IFN responses, which are negatively regulated
by PTPs and DSPs (Fig. 3) (Shuai & Liu, 2003; T. R. Wu et al., 2002; Xu & Qu, 2008).
As demonstrated in Fig. 8B, P-STAT1 is not detectable in the nucleus after treatment of
mESCs with IFN. I speculated that PTPs and DSPs could be factors that contribute to
the attenuated IFN responses in mESCs. To test this possibility, I first examined the
basal mRNA and protein expression level of several PTPs and DSPs in mESCs and
mESC-FBs. As shown in Fig. 11A (a and b), the basal mRNA levels of the tested protein
phosphatases were all relatively higher in mESCs than mESC-FBs. While the basal
protein levels of most of the tested protein phosphatases was comparable between both
cell types, SHP-2 was more highly expressed in mESCs than mESC-FBs. SHP-2 and
other tested protein phosphatase have been reported to tightly regulate STAT1 signal
transduction (Greenhalgh & Hilton, 2001; P. T. M. and C. Wu, 1996; T. R. Wu et al.,
2002; Xu & Qu, 2008). The effects of IFN on the mRNA expression of different protein
phosphatases were also determined. As shown in Fig. 11B, IFN significantly
downregulated the expression of MKP1 and SHP-1 in mESCs, while there were no
significant effects in mESC-FBs. Therefore, the relatively high basal mRNA level of
tested protein phosphatases and the high expression of SHP-2 in mESCs may be potential
factors that limit the mESCs’ responses to IFN.
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Figure 11. Relative expression levels of protein phosphatases that regulate IFNγ signaling
and their induction by IFNγ.
(A) Relative basal mRNA level of protein phosphatases in ESCs and ESC-FBs was compared after normalization to 𝛽-actin mRNA in
each cell type (a). The basal protein level of various protein phosphatase was determined by flow cytometry (Red curve) (b). (B) ESCs
or ESC-FBs were treated with IFNγ (20ng/ml) for 12 h or 24 h. Effects of IFNγ on the mRNA expression of protein phosphatases in
ESCs and ESC-FBs were determined by RT-qPCR. RT-qPCR data are mean ± SD of representative experiments from three
independent experiments. *p < 0.05. Flow cytometry data are derived from a representative experiment that was performed three times
yielding similar results.

Effects of PTP Inhibitor on the Responses of mESCs to IFNγ
Based on the above results, the relatively high expression of protein phosphatases
in mESCs was speculated as a potential factor that causes mESCs’ attenuated responses
to IFN. To test this, I measured the mRNA level of major IFN signaling molecule after
pre-treating mESCs with the general PTP inhibitor vanadate (Vn) (Huyer et al., 1997) for
30min, followed by IFN treatment for 3 h. IRF-1 mRNA expression was then analyzed
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by RT-qPCR. As compared with each control from designated groups, IRF-1 was
significantly upregulated by IFN in Vn-pretreated mESCs, with higher concentrations of
Vn can induceing higher induction of IRF-1 in the presence of IFN (Fig. 12). The above
results suggest that PTPs and DSPs contribute to the attenuated mESCs’ responses to
IFN.

Figure 12. Vn upregulates the response of mESCs to IFNγ.
ESCs were treated with IFNγ (20ng/ml) alone or IFNγ plus Vn (25 or 50nm) for 3 h. mRNA induction of IRF-1 was determined after
normalization to control mRNA in each group. Data are mean ± SD of representative experiments from three independent
experiments. *p < 0.05.
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CHAPTER V – DISCUSSION
The finding of the underdeveloped innate immunity in both mouse and human
ESCs has attracted increasing attention due to the fact that the innate immune response is
an important concerns for their applications in tissue engineering and regenerative
medicine (L.-L. Chen et al., 2010; D’Angelo et al., 2017; Földes et al., 2010; Wang et al.,
2013). While several studies have revealed some possible explanations for the lacking or
low responses to several infectious or inflammatory stimuli in mESCs, innate immune
responses are a complicated subject that needs to be further investigated. The biological
implications of this special property of mESCs remain to be elucidated.
In this study, I first demonstrated the insensitivity of mESCs to the cytotoxic
effects of several different inflammatory conditions, including TNF, LPS-CM, HKE,
and their synergistic effects with IFN, as compared with the differentiated cell model
mESC-FBs. This insensitivity correlates with the attenuated signaling pathway activity
and lack of induction of inflammatory molecules after the designated treatments in
mESCs. Like a double-edged sword, the inflammatory responses can inhibit invasion of
various pathogens, but they can also cause collateral cell damage including cell cycle
arrest and eventually cell death (Hertzog et al., 1994; Kotredes & Gamero, 2013; Sedger
& McDermott, 2014). Thus, these results suggest that the attenuated innate immune
responses in mESCs could help them evade the toxic effects from inflammatory
conditions and maintain their viability as well as the pluripotent capability. However,
most of the molecular mechanisms behind their attenuated responses are still not clear.
IFN is robustly produced by the maternal uterine natural killer cells during the
early stage of the embryogenesis (Ashkar et al., 2000; Platt & Hunt, 1998) and it is also
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one of the most important inflammatory cytokines that would be induced during
different types of inflammation (Boehm et al., 1997; Stark, Kerr, Williams, Silverman, &
Schreiber, 1998). In this study, I further investigated the potential molecular mechanisms
behind mESCs’ attenuated responses. I found that STAT1, a major transcription factor
induced by IFN signaling, is not activated in mESCs, although they express IFN
receptors and associated factors at mRNA and protein levels similar to mESC-FBs. I next
found that siRNA-mediated knockdown of SOCS1, one of the negative regulators of
IFN pathway, did not increase responsiveness of mESCs to IFN, indicating that SOCS1
is unlikely the critical repressor in this context. However, several PTPs were found to
have higher basal mRNA levels in mESCs than mESC-FBs, though at the protein level,
only SHP-2 was more highly expressed in mESCs. Pre-treating mESCs with the general
PTP inhibitor Vn was shown to upregulate the mRNA induction level of IRF-1 by IFN,
which indicates an elevated responsiveness to IFN. Thus, the higher basal expression of
protein phosphatases could, at least in part, explain the attenuated responses of mESCs to
IFN.
It is interesting to note that studies of trophoblast stem cells and trophoblasts,
which compose the outer layer of the blastocyst that surrounds ESCs, showed that those
cells also have selective attenuated responses to IFN (Albieri et al., 2005; J. C. Choi,
Holtz, Petroff, Alfaidy, & Murphy, 2007; Jason C. Choi, Holtz, & Murphy, 2009) and are
resistant to apoptosis induced by IFN, which are believed to be important for
maintaining the integrity of the placenta and successful conception (Sun, Peng, & Xia,
2006; Yui, Garcia-Lloret, Wegmann, & Guilbert, 1994). While embryogenesis involves
intricate interactions between the ICM and trophectoderm, it would be physically more
38

relevant to explore the immune properties of the blastocyst to unveil the development of
the innate immune system during the early stages of embryogenesis. Recent studies that
have generated in vitro models of blastocyst development will provide more
opportunities for a deeper understanding of the early stages of organismal development
and answering the fundamental questions in developmental and stem cell biology
(Harrison, Sozen, Christodoulou, Kyprianou, & Zernicka-Goetz, 2017; Rivron et al.,
2018).
In summary, this study demonstrated that the resistance of mESCs to the
cytotoxic effects from different infections or inflammatory conditions, which is due to
their attenuated responses to inflammation cytokines and bacterial cytokines, could be a
self-protective mechanism. High expression levels of protein phosphatases in mESCs,
especially SHP-2, could be the molecular basis that partially explains their attenuated
responses to IFN. Together with the lacking response of ESCs to TNF demonstrated in
our previous studies, the data presented in this thesis provide additional evidence that
underdeveloped innate immunity is an intrinsic property of ESCs making them less
vulnerable to cytotoxicity associated with inflammatory responses and infection.
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